Science Corporation has successfully implanted its proprietary vision-restoring chip, PRIMA, into the first patient diagnosed with Stargardt disease. This significant advancement marks a new frontier in treating the inherited eye condition that progressively diminishes central vision. Max Hodak, CEO of Science Corporation and former president and co-founder of Neuralink, revealed the development, emphasizing how the […]